𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of the Fas/FasL pathway in combination therapy with interferon-α and fluorouracil against hepatocellular carcinoma in vitro

✍ Scribed by Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Bazarragchaa Damdinsuren; Takehiro Noda; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Keizo Dono; Morito Monden

Book ID
116651187
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
632 KB
Volume
46
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α and 5-fluorouracil combinat
Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules
✍ Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the